| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 66 |
| 1 | TACROLIMUS | 60 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 54 |
| 3 | TACROLIMUS OINTMENT 0.1% | 54 |
| 4 | METHOTREXATE SODIUM | 47 |
| 5 | METHOTREXATE | 42 |
| 6 | ADALIMUMAB | 40 |
| 7 | VEDOLIZUMAB | 36 |
| 8 | MYCOPHENOLATE MOFETIL | 35 |
| 9 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 35 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALFUZOSIN HYDROCHLORIDE | 6 | 0.0024 |
| 1 | TREOSULFAN | 5 | 0.0018 |
| 2 | BASILIXIMAB | 17 | 0.0014 |
| 3 | VANCOMYCIN HYDROCHLORIDE | 11 | 0.0013 |
| 4 | CEFOTAXIME INJECTION | 5 | 0.0011 |
| 5 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 9 | 0.0011 |
| 6 | CARMUSTINE | 5 | 0.0011 |
| 7 | VALGANCICLOVIR | 18 | 0.0009 |
| 8 | THIOTEPA | 7 | 0.0007 |
| 9 | MYCOPHENILIC ACID | 15 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 129 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 45 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 44 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 39 |
| 4 | Integrin Receptor Antagonist [EPC] | 38 |
| 5 | Vitamin C [EPC] | 34 |
| 6 | Proton Pump Inhibitor [EPC] | 33 |
| 7 | Kinase Inhibitor [EPC] | 31 |
| 8 | Vitamin D [EPC] | 30 |
| 9 | Alkylating Drug [EPC] | 29 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tubulin Inhibiting Agent [EPC] | 1 | 0.0034 |
| 1 | CD3-directed Antibody [EPC] | 1 | 0.0014 |
| 2 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 3 | 0.0009 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 5 | 0.0009 |
| 4 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 18 | 0.0008 |
| 5 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 6 | Antimetabolite Immunosuppressant [EPC] | 15 | 0.0007 |
| 7 | Provitamin D2 Compound [EPC] | 19 | 0.0006 |
| 8 | Selective T Cell Costimulation Blocker [EPC] | 3 | 0.0006 |
| 9 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 2 | 0.0006 |